Share

October 22, 2013; 81 (17) Article

Risk of Parkinson disease after depression

A nationwide population-based study

Cheng-Che Shen, Shih-Jen Tsai, Chin-Lin Perng, Benjamin Ing-Tiau Kuo, Albert C. Yang
First published October 2, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a956ad
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
341

Share

Article Information

vol. 81 no. 17 1538-1544
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a956ad
PubMed: 
24089392
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received February 1, 2013
  • Accepted in final form July 26, 2013
  • First Published October 2, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Cheng-Che Shen, MD,
    2. Shih-Jen Tsai, MD,
    3. Chin-Lin Perng, MD,
    4. Benjamin Ing-Tiau Kuo, MD, PhD and
    5. Albert C. Yang, MD, PhD
  1. Cheng-Che Shen, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Shih-Jen Tsai, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board of the Journal: 1). Current Pharmacogenomics and Personalized Medicine(2006∼now), 2). Progress in Neuro-Psychopharmacology and Biological Psychiatry(2007∼now), 3). Taiwanese Journal of Psychiatry, and (2008∼now)4). TheScientificWorldJOURNAL(2010∼now)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. grant NSC100-2314-B-075-042 from the National Science Council, Taiwan (PI, 2011∼now) 2. grants V99ER3-004 and VGHUST100-G1-4-1 from Taipei Veterans General Hospital, Taiwan(PI, 2011∼now)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Chin-Lin Perng, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Benjamin Ing-Tiau Kuo, MD, PhD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Albert C. Yang, MD, PhD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 2012- Editorial Board International Scholarly Research Network (ISRN) Geriatrics 2012 Co-guest Editor Special issue: “Complexity of Mental Illness” Progress in Neuro-Psychopharmacology & Biological Psychiatry

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Psychiatry (C.-C.S.), Chiayi Branch, Taichung Veterans General Hospital; Department of Information Management (C.-C.S.), National Chung-Cheng University, Chiayi; Department of Psychiatry (S.-J.T., A.C.Y.), Division of Gastroenterology, Department of Medicine (C.-L.P.), and Department of Research and Medication (B.I.-T.K.), Taipei Veterans General Hospital; School of Medicine (S.-J.T., C.-L.P., B.I.-T.K., A.C.Y.), National Yang-Ming University, Taipei; and Center for Dynamical Biomarkers and Translational Medicine (A.C.Y.), National Central University, Chungli, Taiwan.
  1. Correspondence to Dr. Yang: accyang{at}gmail.com
View Full Text

Article usage

Article usage: October 2013 to April 2021

AbstractFullPdfSource
Oct 2013553918131Highwire
Nov 201313713049Highwire
Dec 201353678Highwire
Jan 20145661014Highwire
Feb 201434974Highwire
Mar 201443754Highwire
Apr 201445246Highwire
May 2014340189Highwire
Jun 201420801Highwire
Jul 201415612Highwire
Aug 201422422Highwire
Sep 201437130Highwire
Oct 201424014Highwire
Nov 201416300Highwire
Dec 201417924Highwire
Jan 201512012Highwire
Feb 201510811Highwire
Mar 201517944Highwire
Apr 20157801Highwire
May 201514044Highwire
Jun 201512723Highwire
Jul 201514111Highwire
Aug 201511301Highwire
Sep 201512734Highwire
Oct 201513523Highwire
Nov 20158005Highwire
Dec 201510601Highwire
Jan 201610504Highwire
Feb 20169823Highwire
Mar 201613210Highwire
Apr 20167200Highwire
May 201610000Highwire
Jun 20168610Highwire
Jul 20166401Highwire
Aug 20166510Highwire
Sep 201615511Highwire
Oct 201617200Highwire
Nov 20168100Highwire
Dec 20168312Highwire
Jan 20179501Highwire
Feb 20179213Highwire
Mar 20178701Highwire
Apr 201710711Highwire
May 20177700Highwire
Jun 20177000Highwire
Jul 20175700Highwire
Aug 20176322Highwire
Sep 20177700Highwire
Oct 201710811Highwire
Nov 201710402Highwire
Dec 20178001Highwire
Jan 201811501Highwire
Feb 20189132Highwire
Mar 201811772Highwire
Apr 201810230Highwire
May 201812521Highwire
Jun 20188720Highwire
Jul 201810411Highwire
Aug 20189711Highwire
Sep 20186013Highwire
Oct 20187600Highwire
Nov 20188400Highwire
Dec 20187700Highwire
Jan 20197813Highwire
Feb 20196731Highwire
Mar 20198354Highwire
Apr 20196921Highwire
May 20198011Highwire
Jun 20195300Highwire
Jul 20199132Highwire
Aug 20196311Highwire
Sep 20194501Highwire
Oct 20199322Highwire
Nov 201911112Highwire
Dec 20196704Highwire
Jan 20206411Highwire
Feb 20208910Highwire
Mar 20207001Highwire
Apr 20208000Highwire
May 20205600Highwire
Jun 20207133Highwire
Jul 20205000Highwire
Aug 20205400Highwire
Sep 20207611Highwire
Oct 20207000Highwire
Nov 20208910Highwire
Dec 202010801Highwire
Jan 20218712Highwire
Feb 20219511Highwire
Mar 202111313Highwire
Apr 202114544Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me